Cited by 383Complement system in diseasesAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Activation of the classical complement pathway in brain tissue of Alzheimer patients

McGeer, P.L., Akiyama, H., Itagaki, S., McGeer, E.G.·1989·Neuroscience Letters

DOI 10.1016/0304-3940(89)90843-4

Open this paper in CoChat — free account

Abstract

Positive immunohistochemical staining of Alzheimer brain tissue was obtained with antibodies to proteins associated with classical, but not the alternative, complement pathway. Clq, C3d, C4d are fractions of complement proteins that bind to tissue when the classical complement pathway is activated. Antibodies to these fractions stained senile plaques, dystrophic neurites and some neurofibrillary tangles. C5b-9 is the membrane attack complex which promotes cell lysis when assembled on the plasma membrane. An antibody to a neoantigenic site on this complex stained dystrophic neurites and many neurofibrillary tangles, but not extracellular amyloid. Properdin and fraction Bb of factor B, two proteins that bind to tissue when the alternative complement pathway is activated, were not detected immunohistochemically.

Integrity signals

Registry

Crossref · 10.1016/0304-3940(89)90843-4

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940
Self-citation
Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR
McGeer, P. L., Itagaki, S., Tago, H., & McGeer, E. G. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90696-3 · Cited by 836
Self-citation
Expression of immune system-associated antigens by cells of the human central nervous system: Relationship to the pathology of Alzheimer's disease
Rogers, J., Luber-Narod, J., Styren, S. D., & Civin, W. H. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80079-4 · Cited by 743
Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454
Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease
Selkoe, D. J., Abraham, C. R., Podlisny, M. B., & Duffy, L. K. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb08501.x · Cited by 452
Complement activation in amyloid plaques in Alzheimer’s dementia
Eikelenboom, P., Hack, C. E., Rozemüller, A. J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288
A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by? protein immunostaining
YAMAGUCHI, H., Hirai, S., Morimatsu, M., Shoji, M., & Ihara, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00689591 · Cited by 283
Presence of T-cytotoxic suppressor and leucocyte common antigen positive cells in Alzheimer's disease brain tissue
Itagaki, S., McGeer, P. L., & Akiyama, H. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90690-8 · Cited by 271
Self-citation
BASIC AND CLINICAL IMMUNOLOGY
Gatenby, P. A., & Axiak, S. M. (1988) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1988.tb02238.x · Cited by 269
An immunohistochemical study on cerebral vascular and senile plaque amyloid in Alzheimer’s dementia
Eikelenboom, P., & Stam, F. C. (1984) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890185 · Cited by 83

Show all 15 references

Research works printed but not linked: 1

Kolb, 1988, Development of a highly sensitive capture EIA for the quantitation of the SC5b-9 complex in human plasma using a monoclonal antibody reactive with a poly-C9 neoantigenic determinant, Complement, 5, 213

Sorted by citations

Items 201–300 of 383

Alzheimer's disease plaques and tangles: Cemeteries of a Pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction
Carter, C. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.12.003 · Cited by 44
Tissue factor antigen in senile plaques of Alzheimer's disease.
McComb, R. D., Miller, K. A., & Carson, S. D. (1991) · PubMed Central · Cited by 44
Neuroimmunology of Alzheimer's disease: A conference report
Dickson, D. W., & Rogers, J. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90104-6 · Cited by 44
Neuroinflammation in Alzheimer's disease and beneficial action of luteolin
Delgado, A., Cholevas, C., & Theoharides, T. C. (2021) · BioFactors · doi:10.1002/biof.1714 · Cited by 48
IL-1 and anti-inflammatory drugs modulate A β cytotoxicity in PC12 cells
Fágárásan, M. O., & Aisen, P. S. S. (1996) · Brain Research · doi:10.1016/0006-8993(96)00259-4 · Cited by 43
Alzheimer's disease neuropathology and its estimation with fluid and imaging biomarkers
Thal, D. R., Poesen, K., Vandenberghe, R. R., & Meyer, S. D. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00819-y · Cited by 55
Plasma Levels of Complement 4a Protein are Increased in Alzheimer's Disease
Bennett, S. J., Grant, M. M., Creese, A. J., Mangialasche, F., Cecchetti, R., Cooper, H. J., Mecocci, P., & Aldred, S. (2011) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318239dcbd · Cited by 42
Neutrophil Extracellular Traps: A Perspective of Neuroinflammation and Complement Activation in Alzheimer’s Disease
Kretzschmar, G. C., Bumiller‐Bini, V., Filho, M. A. G., Zonta, Y. R., Yu, K. S. T., de Souza, R. L. R., Dias‐Melicio, L. A., & Boldt, A. B. W. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.630869 · Cited by 42
Expression and regulation of complement C1q by human THP-1-derived macrophages
Walker, D. G. (1998) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815080 · Cited by 40
Human postmortem brain-derived cerebrovascular smooth muscle cells express all genes of the classical complement pathway: A potential mechanism for vascular damage in cerebral amyloid angiopathy and Alzheimer's disease
Walker, D. G., Dalsing-Hernandez, J. E., & Lue, L. (2007) · Microvascular Research · doi:10.1016/j.mvr.2007.10.004 · Cited by 39
Is there a future for vaccination as a treatment for Alzheimer's disease?
McGeer, P. L. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00157-4 · Cited by 39
Self-citation
Macrophage colony stimulatory factor and interferon‐γ trigger distinct mechanisms for augmentation of β‐amyloid‐induced microglia‐mediated neurotoxicity
Li, M., Pisalyaput, K., Galvan, M. D., & Tenner, A. J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02765.x · Cited by 38
The wheat germ agglutinin‐fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression
Domenico, F. D., Owen, J. B., Rukhsana Sultana, A., Robinson, R. A. S., Marzia Perluigi, A., Cini, C., Cai, J., Pierce, W. M. J., & Butterfield, D. A. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22528 · Cited by 40
Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of beta-amyloid protein into rodent hippocampus
Miller, J. D., Cummings, J. A., Maresh, G. A., Walker, D. G., Castillo, G. M., Ngo, C., Kimata, K., Kinsella, M. G., Wight, T. N., & Snow, A. D. (1997) · Glia · doi:10.1002/(sici)1098-1136(199710)21:2 · Cited by 38
Complement gene expression in neuroblastoma and astrocytoma cell lines of human origin
Walker, D. G., & McGeer, P. L. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90652-2 · Cited by 38
Self-citation
Role of NETosis in Central Nervous System Injury
Chen, Y., Zhang, H., Hu, X., Cai, W., Ni, W., & Zhou, K. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/3235524 · Cited by 39
Neuropathology of sudden infant death (syndrome): literature review and evidence of a probable apoptotic degenerative cause
Sparks, L. D., & Hunsaker, J. C. (2002) · Child s Nervous System · doi:10.1007/s00381-002-0629-5 · Cited by 37
Deposits of Aβ fibrils are not toxic to cortical and hippocampal neurons in vitro
Wujek, J. R., Dority, M. D., Frederickson, R. C. A., & Brunden, K. R. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02020-9 · Cited by 36
Astrocytic messenger RNA responses to striatal deafferentation in male rat
Pasinetti, G. M., Cheng, H. W., Morgan, D., Lampert-Etchells, M., McNeill, T. H., & Finch, C. E. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90298-t · Cited by 38
Imaging microglial activation and amyloid burden in amnestic mild cognitive impairment
Knezevic, D., Verhoeff, N. P. L. G., Hafizi, S., Strafella, A. P., Graff‐Guerrero, A., Rajji, T. K., Pollock, B. G., Houle, S., Rusjan, P., & Mizrahi, R. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17741395 · Cited by 38
Clusterin/ApoJ expression is associated with neuronal apoptosis in the olfactory mucosa of the adult mouse
Michel, D., Moyse, E., Trembleau, A., Jourdan, F., & Brun, G. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.14.1635 · Cited by 36
Pick's disease immunohistochemistry: new alterations and Alzheimer's disease comparisons
Yasuhara, O., Matsuo, A., Tooyama, I., Kimurâ, H., McGeer, E. G., & McGeer, P. L. (1995) · Acta Neuropathologica · doi:10.1007/bf00309625 · Cited by 36
Self-citation
Evidence for enhanced neuro-inflammatory processes in neurodegenerative diseases and the action of nitrones as potential therapeutics
Floyd, R. A., Hensley, K., & Bing, G. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_28 · Cited by 34
Neuropathology of Alzheimer's Disease and its Variants
Duyckaerts, C. J., & Dickson, D. W. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch10 · Cited by 36
Amyloids: The History of Toxicity and Functionality
Yakupova, E. I., Bobyleva, L. G., Shumeyko, S. A., Vikhlyantsev, I. M., & Bobylev, A. G. (2021) · Biology · doi:10.3390/biology10050394 · Cited by 34
Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease
O’Banion, M. K., & Finch, C. E. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00102-9 · Cited by 33
Nonsteroidal Anti-Inflammatory Drugs and Cognitive Function
Karplus, T. M., & Saag, K. G. (1998) · Drug Safety · doi:10.2165/00002018-199819060-00001 · Cited by 33
Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels
Veteleanu, A., Stevenson‐Hoare, J. O., Keat, S., Daskoulidou, N., Zetterberg, H., Heslegrave, A., Escott‐Price, V., Williams, J. H., Sims, R., Zelek, W. M., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02850-6 · Cited by 34
Propionibacterium acnes in the cortex of patients with Alzheimer's disease
Kornhuber, H. H. (1996) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02274902 · Cited by 32
Anti-α4β1 Integrin Antibodies Attenuated Brain Inflammatory Changes in a Mouse Model of Alzheimer’s Disease
Manocha, G. D., Ghatak, A., Puig, K. L., & Combs, C. K. (2018) · Current Alzheimer Research · doi:10.2174/1567205015666180801111033 · Cited by 30
Cerebrospinal Fluid C3a Increases with Age, But Does Not Increase Further in Alzheimer’s Disease
Loeffler, D. A., Brickman, C. M., Juneau, P. L., Perry, M. F., Pomara, N., & LeWitt, P. A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00110-3 · Cited by 31
Alzheimer's disease and age-related macular degeneration have different genetic models for complement gene variation
Proitsi, P., Lupton, M. K., Dudbridge, F., Tsolaki, M., Hamilton, G., Daniilidou, M., Pritchard, M., Lord, K., Martin, B. M., Craig, D., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.036 · Cited by 31
INFLAMMATION AND ALZHEIMER'S DISEASE
Gupta, A., & Pansari, K. (2003) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2003.tb11394.x · Cited by 31
Dynamics of the Complement, Cytokine, and Chemokine Systems in the Regulation of Synaptic Function and Dysfunction Relevant to Alzheimer’s Disease
Jiang, S., & Bhaskar, K. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161123 · Cited by 31
Fleeting Activation of Ionotropic Glutamate Receptors Sensitizes Cortical Neurons to Complement Attack
Xiong, Z., & McNamara, J. O. (2002) · Neuron · doi:10.1016/s0896-6273(02)00977-7 · Cited by 29
Complement dysregulation and Alzheimer's disease in Down syndrome
Veteleanu, A., Pape, S. E., Davies, K., Kodosaki, E., Hye, A., Zelek, W. M., Strydom, A., & Morgan, B. P. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12799 · Cited by 29
Oxidative Stress in Alzheimer’s Disease: The Shortcomings of Antioxidant Therapies
Pappolla, M. A., Martins, R. N., Poeggeler, B., Omar, R. A., & Perry, G. (2024) · Journal of Alzheimer's Disease · doi:10.3233/jad-240659 · Cited by 29
Cajal's Contributions to the Study of Alzheimer's Disease
García‐Marín, V., García-López, P., & Freire, M. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12206 · Cited by 29
APP, APOE, complement receptor 1, clusterin and PICALM and their involvement in the herpes simplex life cycle
Carter, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.07.066 · Cited by 29
Silencing of theWFS1gene in HEK cells induces pathways related to neurodegeneration and mitochondrial damage
Kõks, S., Overall, R. W., Ivask, M., Soomets, U., Guha, M., Vasar, E., Fernandes, C., & Schalkwyk, L. C. (2013) · Physiological Genomics · doi:10.1152/physiolgenomics.00122.2012 · Cited by 28
Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic acid synthetic complex
Lee, M., Guo, J., Schwab, C., McGeer, E. G., & McGeer, P. L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.005 · Cited by 27
Self-citation
Detection of complement factor B in the cerebrospinal fluid of patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy disease using two-dimensional gel electrophoresis and mass spectrometry
Unlü, M. D., de Lange, R. P. J., de Silva, R. N., Kalaria, R. N., & Clair, D. S. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00875-2 · Cited by 28
Anti-inflammatory substances – a new therapeutic option in Alzheimer's disease
Hüll, M. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01339-2 · Cited by 27
Herpesviral infections and antimicrobial protection for Alzheimer's disease: Implications for prevention and treatment
Qin, Q., & Li, Y. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25481 · Cited by 26
Inflammation and Alzheimerʼs Disease
Rogers, J. (1994) · CNS Drugs · doi:10.2165/00023210-199401040-00001 · Cited by 26
The Role of Complement in Stroke Therapy
Komotar, R. J., Kim, G. H., Otten, M. L., Hassid, B. G., Mocco, J., Sughrue, M. E., Starke, R. M., Mack, W. J., Ducruet, A. F., Merkow, M. B., et al. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_2 · Cited by 25
Alzheimer’s Silent Partner: Cerebral Amyloid Angiopathy
Cupino, T. L., & Zabel, M. K. (2013) · Translational Stroke Research · doi:10.1007/s12975-013-0309-7 · Cited by 27
Correlation of the Expression Level of C1q mRNA and the Number of C1q-Positive Plaques in the Alzheimer Disease Temporal Cortex
Tooyama, I., Sato, H., Yasuhara, O., Kimura, H., Konishi, Y., Shen, Y., Walker, D. G., Beach, T. G., Sue, L. I., & Rogers, J. (2001) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000051265 · Cited by 24
Immune Responses in Brains of Alzheimer's and Parkinson's Disease Patients: Hypothesis and Reality
McRae‐Degueurce, A., & Dahlström, A. B. (1992) · Reviews in the Neurosciences · doi:10.1515/revneuro.1992.3.2.79 · Cited by 23
Chronic intracerebroventricular infusion of lipopolysaccharide: effects of ibuprofen treatment and behavioural and histopathological correlates
Richardson, R. L., Kim, E.-M., Gardiner, T. A., & O‘Hare, E. (2005) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000179278.03868.96 · Cited by 22
Immunological Aspects of Alzheimer??s Disease
Hoozemans, J. J. M., Rozemüller, A. J. M., Veerhuis, R., & Eikelenboom, P. (2001) · BioDrugs · doi:10.2165/00063030-200115050-00004 · Cited by 21
Evidence that neurofibrillary tangles undergo glial modification
Ikeda, K., Akiyama, H., Haga, C., & Haga, S. (1992) · Acta Neuropathologica · doi:10.1007/bf00304639 · Cited by 21
Self-citation
Inflammatory Markers in Chronic Neurodegenerative Disorders with Emphasis on Alzheimer’s Disease
Walker, D. G. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-473-3_2 · Cited by 21
Inflammatory Mediators in Alzheimer’s Disease
Rogers, J., & O’Barr, S. A. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_11 · Cited by 19
Molecular identification of protein kinase C beta in Alzheimer's disease
Zhou, Z., Chen, F., Zhong, S., Zhou, Y., Zhang, R., Kang, K., Zhang, X., Xu, Y., Zhao, M., & Zhao, C. (2020) · Aging · doi:10.18632/aging.103994 · Cited by 19
Tau Spread, Apolipoprotein E, Inflammation, and More
Gonzalez, B. L., Abud, E. M., Abud, A. M., Poon, W. W., & Gylys, K. H. (2017) · Neurologic Clinics · doi:10.1016/j.ncl.2017.01.001 · Cited by 20
Sulfated Glycoprotein‐2: An Emerging Molecular Marker for Neurodegeneration
May, P. C. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb18303.x · Cited by 20
An Analysis of the Neurological and Molecular Alterations Underlying the Pathogenesis of Alzheimer’s Disease
Vidal, C., & Li, Z. (2021) · Cells · doi:10.3390/cells10030546 · Cited by 20
Alzheimer's disease cerebrospinal fluid antibodies display selectivity for microglia
Dahlström, A. B., McRae‐Degueurce, A., Polinsky, R. J., Nee, L. E., Sadasivan, B., & Ling, E. A. (1994) · Molecular Neurobiology · doi:10.1007/bf02816104 · Cited by 19
Supported Lipid Bilayer Platform To Test Inhibitors of the Membrane Attack Complex: Insights into Biomacromolecular Assembly and Regulation
Avsar, S. Y., Jackman, J. A., Hunziker, W., & Cho, N. (2015) · Biomacromolecules · doi:10.1021/acs.biomac.5b01060 · Cited by 18
Expression and function of membrane regulators of complement on rat astrocytes in culture
ROGERS, C. A., Gasque, P., Piddlesden, S. J., Okada, N., Holers, V. M., & Morgan, B. P. (1996) · Immunology · doi:10.1046/j.1365-2567.1996.d01-637.x · Cited by 18
Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression
Spiller, O. B., Moretto, G., Kim, S. U., Morgan, B. P., & Devine, D. V. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00136-1 · Cited by 18
Early complement activation increases in the brain in some aged normal subjects
Loeffler, D. A., Camp, D. M., Schonberger, M. B., Singer, D. J., & LeWitt, P. A. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.11.003 · Cited by 18
Strategies for Inhibition of Complement Activation in the Treatment of Neurodegenerative Diseases
Spiegel, K., Emmerling, M. R., & Barnum, S. R. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-473-3_5 · Cited by 18
Cerebrospinal fluid microglial antibodies: Potential diagnostic markers for immune mechanisms in Alzheimer's disease
McRae‐Degueurce, A., Dahlström, A. B., Polinsky, R. J., & Ling, E. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90139-h · Cited by 18
Complement System in Central Nervous System Disorders
Shin, M. L., Rus, H., & Niculescu, F. I. (1998) · CRC Press eBooks · doi:10.1201/b14212-24 · Cited by 18
Using animal models to determine the significance of complement activation in Alzheimer's disease.
Loeffler, D. A. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-18 · Cited by 17
Expression of Ly-6C on microglia in the developing and adult mouse brain
Tanaka, M., Marunouchi, T., & Sawada, M. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00878-1 · Cited by 17
Immunotherapy for Alzheimer's Disease
McGeer, P. L., & McGeer, E. G. (2004) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2004.27.pe29 · Cited by 16
Self-citation
Acidic FGF Expression in the Surroundings of Senile Plaques.
Kimura, H., Tooyama, I., & McGeer, P. L. (1994) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.174.279 · Cited by 16
Self-citation
Immunoblot detection of antibodies to myelin basic protein in Alzheimer's disease patients
Singh, V. K., Yang, Y., & Singh, E. A. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90766-z · Cited by 16
Complement in diseases of the nervous system
Morgan, B. P. (1993) · Springer eBooks · doi:10.1007/978-94-011-2214-6_13 · Cited by 15
Chapter 24. Amyloidogenesis as a Therapeutic Target in Alzheimer's Disease
Greenberg, B., Kezdy, F. J., & Kisilevsky, R. (1991) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61211-7 · Cited by 15
Inflammatory Mechanisms of Alzheimer’s Disease
Rogers, J., & Griffin, W. S. T. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-473-3_6 · Cited by 14
IMMUNOSENESCENCE-RELATED DISEASES IN THE ELDERLY
Effros, R. B. (1993) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(22)00422-2 · Cited by 14
Investigation of Potential Drug Targets Involved in Inflammation Contributing to Alzheimer’s Disease Progression
Sharo, C., Zhai, T., & Huang, Z. J. (2024) · Pharmaceuticals · doi:10.3390/ph17010137 · Cited by 13
Neurodegenerative Diseases
Gómez‐Nicola, D., & Perry, V. H. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_18 · Cited by 13
Induction of complement C9 messenger RNAs in human neuronal cells by inflammatory stimuli: relevance to neurodegenerative disorders
Klegeris, A. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00265-5 · Cited by 13
Type 2 Diabetes: Local Inflammation and Direct Effect of Bacterial Toxic Components
Judith Miklossy, A., Martins, R. N., Darbinian, N., Khalili, K., & McGeer, P. L. (2008) · The Open Pathology Journal · doi:10.2174/1874375700802010086 · Cited by 13
Self-citation
Virus-Like Cytosolic and Cell-Free Oxidatively Damaged Nucleic Acids Likely Drive Inflammation, Synapse Degeneration, and Neuron Death in Alzheimer’s Disease
Sanders, O. D. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-220047 · Cited by 13
Unique Expression of HRF20 (CD59) in Human Nervous Tissue
Akatsu, H., Yamada, T., Okada, N., Yamamoto, T., Yamashina, M., & Okada, H. (1997) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1997.tb01208.x · Cited by 12
Aurin tricarboxylic acid self-protects by inhibiting aberrant complement activation at the C3 convertase and C9 binding stages
Lee, M., Guo, J., McGeer, E. G., & McGeer, P. L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.023 · Cited by 12
Self-citation
β-Amyloid Peptides Initiate the Complement Cascade without Producing a Comparable Effect on the Terminal Pathwayin Vitro
Cadman, E. D., & Puttfarcken, P. S. (1997) · Experimental Neurology · doi:10.1006/exnr.1997.6540 · Cited by 12
Expression and processing of pathologic proteins in alzheimer's disease
Anderton, B. H. (1993) · Hippocampus · doi:10.1002/hipo.1993.4500030726 · Cited by 12
Factors produced by activated macrophages reduce accumulation of Alzheimer's β-amyloid protein in vascular smooth muscle cells
Mazur‐Kolecka, B., Frackowiak, J., LeVine, H., Haske, T., & Wı́sniewski, H. M. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00327-2 · Cited by 12
Recruiting the innate immune system with GM-CSF to fight viral diseases, including West Nile Virus encephalitis and COVID-19
Potter, H., Boyd, T. D., Clarke, P., Pelak, V. S., & Tyler, K. L. (2020) · F1000Research · doi:10.12688/f1000research.23729.1 · Cited by 11
The Complement System: A Potential Target for Stroke Therapy
Mocco, J., Sughrue, M. E., Ducruet, A. F., Komotar, R. J., Sosunov, S. A., & Connolly, E. S. (2006) · Advances in experimental medicine and biology · doi:10.1007/0-387-34134-x_13 · Cited by 11
Immunoreactivity patterns in neurofibrillary tangles of the inferior temporal cortex in Alzheimer disease
Duong, T., & Gallagher, K. A. (1994) · Molecular and Chemical Neuropathology · doi:10.1007/bf03160099 · Cited by 11
Hypothalamic gene expression profile indicates a reduction in G protein signaling in theWfs1mutant mice
Kõks, S., Soomets, U., Plaas, M., Terasmaa, A., Noormets, K., Tillmann, V., Vasar, E., Fernandes, C., & Schalkwyk, L. C. (2011) · Physiological Genomics · doi:10.1152/physiolgenomics.00117.2011 · Cited by 10
Impaired regulation of immune responses in cognitive decline and Alzheimer’s disease: lessons from genetic association studies
Chiappelli, M., Tumini, E., Porcellini, E., & Licastro, F. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.9.1327 · Cited by 10
Activation of complement by tissue plasminogen activator, but not acute cerebral ischemia, in a rabbit model of thromboembolic stroke
Bednar, M. M., Gross, C. E., Russell, S. R., Short, D., & Giclas, P. C. (1997) · Journal of neurosurgery · doi:10.3171/jns.1997.86.1.0139 · Cited by 10
The complement cascade in Alzheimer’s disease: modern implications of an ancient immune protagonist
Papavergi, M.-T., Bathini, P., Singh, B. B., & Lemere, C. A. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00916-y · Cited by 12
Prostacyclin Promotes Degenerative Pathology in a Model of Alzheimer’s Disease
Womack, T., Vollert, C. T., Ohia-Nwoko, O., Schmitt, M. E., Montazari, S., Beckett, T. L., Mayerich, D. M., Murphy, M. P., & Eriksen, J. L. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.769347 · Cited by 8
Complement Gene Single Nucleotide Polymorphisms and Biomarker Endophenotypes of Alzheimer's Disease
Daborg, J., Holmgren, S., Abramsson, A., Andréasson, U., Zetterberg, M., Nilsson, S., Minthon, L., Skoog, I. G., Blennow, K., Pekna, M., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121930 · Cited by 9
Potential Intervention by Vaccinia Virus Complement Control Protein of the Signals Contributing to the Progression of Central Nervous System Injury to Alzheimer's Disease
Kotwal, G., Lahiri, D., & Hicks, R. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04659.x · Cited by 11
Brain-immune interactions: implication for cognitive impairments in Alzheimer's disease and autoimmune disorders
Kadam, R., Gupta, M., Lazarov, O., & Prabhakar, B. S. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae134 · Cited by 8
Unveiling the Involvement of Herpes Simplex Virus-1 in Alzheimer’s Disease: Possible Mechanisms and Therapeutic Implications
Chauhan, P., Begum, M. Y., Narapureddy, B. R., Gupta, S., Wadhwa, K., Singh, G., Kumawat, R., Sharma, N., Ballal, S., Jha, S. K., et al. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04535-4 · Cited by 9
Centella asiatica, an Ayurvedic Medicinal Plant, Prevents the Major Neurodegenerative and Neurotoxic Mechanisms Associated with Cognitive Impairment
Ahuja, M., Patel, M., Majrashi, M., Mulabagal, V., & Dhanasekaran, M. (2017) · Medicinal and aromatic plants of the world · doi:10.1007/978-981-10-5978-0_1 · Cited by 9
Impaired Volume Regulation is the Mechanism of Excitotoxic Sensitization to Complement
Loo, L. S., & McNamara, J. O. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2628-06.2006 · Cited by 8
Comparison of C1q-receptors on rat microglia and peritoneal macrophages
Wing, M. G., Seilly, D. J., Nicholas, R. S., Rahman, S., Zajicek, J., Lachmann, P. J., & Compston, D. A. S. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00227-6 · Cited by 8

Authors: McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G.
Affiliations: University of British Columbia (CA)
Corresponding author: McGeer, P.L.
ORCID: McGeer, P.L.
Akiyama, H.
Venue: Neuroscience Letters
Publisher: Elsevier BV
Published: 1989-12
Volume: 107
Issue: 1-3
Pages: 341-346
ISSN: 0304-3940 (ISSN-L)
DOI: 10.1016/0304-3940(89)90843-4
OpenAlex: W1980565738
Cited by: 383
References: 15
Citations by year: 2025: 5 · 2024: 10 · 2023: 7 · 2022: 6 · 2021: 12 · 2020: 7 · 2019: 10 · 2018: 8 · 2017: 9 · 2016: 6 · 2015: 8 · 2014: 12 · 2013: 17 · 2012: 10
FWCI: 3.94
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neuroscience Letters (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: classical complement pathway, Alzheimer's disease, complement activation, C1q, C3d, C4d, C5b-9 membrane attack complex, amyloid plaques, dystrophic neurites, neurofibrillary tangles, amyloid, alternative complement pathway, properdin, factor B
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Brain, Inclusion Bodies, Complement Activation, Complement Pathway, Classical, Complement C4, Humans, Immunohistochemistry, Neurofibrils, Peptide Fragments, Complement C1q, Complement C3d, Complement C4b, Complement Membrane Attack Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Activation of the classical complement pathway in brain tissue of Alzheimer patients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks